# Phase 06 — Bounded Contexts Report

**Execution mode:** Assumption-Driven Autonomous Run.
**Skills applied:** `domain-driven-design` (Context Mapping), `c4-architecture`
(System Context diagram), `mermaid-diagrams` (Context Map, dependency
graph).

## Executive Summary

Formalized 8 Bounded Contexts from Phase 04/05 evidence, resolved the
Specimen Management/Test Processing boundary question (kept separate, with
explicit rationale), labeled all 11 Context Map relationships (zero
unlabeled), confirmed the Module Dependency graph is acyclic, considered
and explicitly rejected a Shared Kernel for Organization/Branch reference
data, and recorded full divergence from `module-catalog.md`'s 16
categories.

## Findings

- The dependency graph collapses cleanly to a single funnel toward Core
  Platform — no context has an outgoing edge that doesn't eventually reach
  Core Platform, which is a healthy sign for a Modular Monolith (Constitution
  Section 9).
- Patient and Doctor remain without a distinct Bounded Context after formal
  boundary-drawing — this could be correct (genuinely cross-cutting Actors)
  or could indicate an undiscovered context; flagged as Risk #7, not
  resolved by assumption.
- The two Independent Components already named in the Constitution
  (Notification Service, Device Integration Gateway — Section 11) map
  cleanly onto 2 of the 8 Discovery contexts, which is a positive
  consistency signal, not a coincidence — those two were classified Generic/
  Supporting independently in Phase 04, before this cross-check was made.

## Decisions

Discovery-level only (not Constitution-Accepted): Specimen Management and
Test Processing remain separate contexts; Organization/Branch stays Open
Host Service, not Shared Kernel. Both carried to Phase 11/12 for
possible ratification.

## Open Questions

No new items — Risk #7 (Patient/Doctor context gap) is logged as a Risk,
not an Open Question, because it's a modeling-completeness concern rather
than a business fact gap.

## Risks

2 new entries (`RISK-REGISTER.md` #7–8).

## Assumptions

Context boundary decisions themselves are `Inferred — Extrapolated` from
Phase 04/05 evidence (not a fresh assumption category — already covered by
prior entries; no new Assumption Register row needed this phase beyond what
Phase 04/05 already logged).

## Missing Information

Same as Phase 04/05 — nothing new surfaced strictly by boundary-drawing
itself.

## Recommendations

- Phase 07 should explicitly test whether Patient/Doctor genuinely need no
  owned Aggregate, or whether a lightweight "Patient Profile"/"Doctor
  Profile" concept is missing (Risk #7).
- Phase 11 should specifically re-verify the Specimen/Test-Processing split
  once more evidence (Phase 07 business rules) exists, since it was the
  single most consequential judgment call this phase made.

## DDD Consistency Review (Quick Diagnostic, full re-score)

| Diagnostic Row | Result | Note |
|---|---|---|
| Domain-expert-readable names | PASS | All 8 context names and Ubiquitous Language terms are business-readable. |
| Bounded Context boundaries explicitly defined | **PASS** | First phase where this is fully applicable — 8 contexts, 11 labeled relationships, zero unlabeled. |
| Aggregates small | PASS | Carried from Phase 05, unchanged. |
| Domain objects contain behavior | Partial | Structure is boundary-correct; behavioral rules still Phase 07's job. |
| Domain Events used for cross-aggregate communication | PASS | All event-based relationships (Notification, Billing←Test Processing, Device←→Test Processing) explicitly named as such in the Context Map. |
| ACL at every external integration | **PASS** | Device and Equipment Integration's crossing into Test Processing is explicitly labeled Anti-Corruption Layer. |
| Core Subdomain/Context identified | PASS (Proposed) | Test Processing and Result Verification, carried from Phase 04. |

**This is the first phase where the full 7-row diagnostic is meaningfully
scorable — 5 PASS, 1 Partial (expected, Phase 07's job), 0 FAIL.**

## Review Checklist (per Playbook 06)

- [x] Every candidate Aggregate assigned to exactly one Bounded Context.
- [x] Every inter-context relationship has a named Context Mapping
      pattern — none unlabeled.
- [x] Every boundary touching an external system has an ACL noted (Device
      Integration).
- [x] Module Dependency graph confirmed acyclic.
- [x] Shared Kernel explicitly flagged (considered and rejected, with
      reasoning — no ADR triggered since none was adopted).

## Quality Gates

- **Context Map Completeness Gate:** PASS — 11/11 relationships labeled.
- **Acyclic Graph Gate:** PASS — traced and confirmed manually (see
  `06-bounded-contexts.md`).
- **DDD Consistency Review:** PASS (see table above).

## Exit Criteria Confirmation

- [x] Context Map complete, every relationship labeled, acyclic graph
      confirmed, `module-catalog.md` divergence documented.

## Files Updated

- `.claude/context/module-catalog.md` (Candidate Contexts from Discovery
  section appended)
- `.claude/context/glossary.md` (Discovery Phase 06 section, 6 new Draft
  terms)
- `docs/discovery/artifacts/RISK-REGISTER.md` (updated)

## ADR Impact

Likely significant at Phase 12: (1) the Core Domain proposal, if it
survives Phase 11; (2) the Specimen/Test-Processing split, if it proves
structurally important once Phase 07/08 build on it. No Shared Kernel ADR
needed (none was adopted).
